Disc Medicine to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Nov 13, 2024
WATERTOWN, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will present at two upcoming investor conferences:
Read more at globenewswire.com
